▼ -8.68% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Inspire Medical Systems in the last 3 months. The average price target is $177.70, with a high forecast of $275.00 and a low forecast of $50.00. The average price target represents a -8.68% upside from the last price of $194.60.
The current consensus among 9 investment analysts is to buy stock in Inspire Medical Systems. This rating has held steady since February 2020, when it changed from a Hold consensus rating.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.